chr1-154719612-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001204087.2(KCNN3):​c.1747-4609A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.516 in 151,982 control chromosomes in the GnomAD database, including 22,986 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.52 ( 22986 hom., cov: 31)

Consequence

KCNN3
NM_001204087.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.11

Publications

9 publications found
Variant links:
Genes affected
KCNN3 (HGNC:6292): (potassium calcium-activated channel subfamily N member 3) Action potentials in vertebrate neurons are followed by an afterhyperpolarization (AHP) that may persist for several seconds and may have profound consequences for the firing pattern of the neuron. Each component of the AHP is kinetically distinct and is mediated by different calcium-activated potassium channels. This gene belongs to the KCNN family of potassium channels. It encodes an integral membrane protein that forms a voltage-independent calcium-activated channel, which is thought to regulate neuronal excitability by contributing to the slow component of synaptic AHP. This gene contains two CAG repeat regions in the coding sequence. It was thought that expansion of one or both of these repeats could lead to an increased susceptibility to schizophrenia or bipolar disorder, but studies indicate that this is probably not the case. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2011]
KCNN3 Gene-Disease associations (from GenCC):
  • Zimmermann-Laband syndrome 3
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • Zimmermann-Laband syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • schizophrenia
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.814 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001204087.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNN3
NM_002249.6
MANE Select
c.1702-4609A>G
intron
N/ANP_002240.3
KCNN3
NM_001204087.2
c.1747-4609A>G
intron
N/ANP_001191016.1
KCNN3
NM_001365837.1
c.808-4609A>G
intron
N/ANP_001352766.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNN3
ENST00000271915.9
TSL:1 MANE Select
c.1702-4609A>G
intron
N/AENSP00000271915.3
KCNN3
ENST00000361147.8
TSL:1
c.787-4609A>G
intron
N/AENSP00000354764.4
KCNN3
ENST00000358505.2
TSL:1
c.763-4609A>G
intron
N/AENSP00000351295.2

Frequencies

GnomAD3 genomes
AF:
0.516
AC:
78313
AN:
151864
Hom.:
22941
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.821
Gnomad AMI
AF:
0.500
Gnomad AMR
AF:
0.409
Gnomad ASJ
AF:
0.410
Gnomad EAS
AF:
0.277
Gnomad SAS
AF:
0.408
Gnomad FIN
AF:
0.376
Gnomad MID
AF:
0.525
Gnomad NFE
AF:
0.409
Gnomad OTH
AF:
0.455
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.516
AC:
78417
AN:
151982
Hom.:
22986
Cov.:
31
AF XY:
0.508
AC XY:
37765
AN XY:
74272
show subpopulations
African (AFR)
AF:
0.821
AC:
34020
AN:
41446
American (AMR)
AF:
0.408
AC:
6241
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.410
AC:
1421
AN:
3468
East Asian (EAS)
AF:
0.277
AC:
1427
AN:
5154
South Asian (SAS)
AF:
0.407
AC:
1959
AN:
4814
European-Finnish (FIN)
AF:
0.376
AC:
3975
AN:
10574
Middle Eastern (MID)
AF:
0.517
AC:
152
AN:
294
European-Non Finnish (NFE)
AF:
0.409
AC:
27799
AN:
67934
Other (OTH)
AF:
0.460
AC:
968
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1668
3337
5005
6674
8342
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
654
1308
1962
2616
3270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.441
Hom.:
29749
Bravo
AF:
0.530
Asia WGS
AF:
0.412
AC:
1437
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.29
DANN
Benign
0.59
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4845663; hg19: chr1-154692088; API